JP Morgan Chase
AVNR

JP Morgan Chase’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

JP Morgan Chase’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,690,342
Closed -$28.7M – 4487
2014
Q4 		$28.7M Buy
+1,690,342
New +$23.8M 0.01% 1249
2013
Q4 		– Sell
-86,905
Closed -$367K – 4424
2013
Q3 		$367K Sell
86,905
-51,231
-37% -$243K ﹤0.01% 3778
2013
Q2 		$635K Buy
+138,136
New +$475K ﹤0.01% 3485

JP Morgan Chase's AVNR Position: Q1 2015 in Review

JP Morgan Chase sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,690,342 shares — an estimated $28.7M sold.

JP Morgan Chase first reported a position in AVNR in Q2 2013 and held it in 3 quarters. The position peaked at $28.7M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • JP Morgan Chase reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • JP Morgan Chase sold 1,690,342 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $28.7M.
  • JP Morgan Chase first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 3 quarters.
  • JP Morgan Chase's AVANIR PHARMACEUTICALS, INC CL A position peaked at $28.7M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on JP Morgan Chase's 13F filing for Q1 2015, filed 15 May 2015.